Supplementary Financial Statement Information - Schedule of Research and Development Expenses, Net (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Schedule of Research and Development Expenses, Net [Abstract] | |||
| Payroll and related expenses | $ 3,078 | $ 5,265 | $ 6,371 |
| Research and development services | 5,039 | 9,853 | 8,264 |
| Materials | 553 | 1,880 | 2,044 |
| Share Based Compensation | 916 | 524 | 876 |
| Depreciation | 497 | 802 | 740 |
| Other | 540 | 911 | 1,605 |
| Total Research and Development expenses before reimbursement from the Israel Innovation Authority | 10,623 | 19,235 | 19,900 |
| Israel Innovation Authority participation in research and development costs and royalties payable | (223) | (1,207) | |
| Research and development expenses, net | $ 10,623 | $ 19,012 | $ 18,693 |